Erlotinib Tablet
Product Images NDC 68382-913

8 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Erlotinib (NDC 68382-913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 01)

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 01)
Chemical structure of Erlotinib hydrochloride, depicting its molecular framework with labeled atoms and bonds representing the active pharmaceutical ingredient in the Erlotinib oral tablet.*
FDA Label Image

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 02)

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 02)
A Kaplan-Meier plot depicting progression-free survival probability over time in months. The graph compares two groups: one receiving chemotherapy and the other Erlotinib. Survival probability decreases over time, with Erlotinib showing higher survival probability compared to chemotherapy throughout the duration. The number of patients at risk at different time points is listed below for each treatment group.*
FDA Label Image

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 03)

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 03)
A survival probability curve chart comparing overall survival (in months) between Placebo and Erlotinib groups. The x-axis represents time in months up to 36 months, and the y-axis shows survival probability from 0 to 1. The chart includes patient risk numbers at different time points for both groups.*
FDA Label Image

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 04)

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 04)
A survival probability Kaplan-Meier curve comparing overall survival in months between patients treated with Erlotinib tablets and placebo. The chart shows survival probability on the y-axis and overall survival time in months on the x-axis, with patient counts at risk listed below for each group.*
FDA Label Image

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 05)

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 05)
A Kaplan-Meier survival curve chart comparing overall survival probability over time in months between patients treated with Erlotinib and placebo. The graph includes a table below showing the number of patients at risk at various time points for both Erlotinib and placebo groups.*
FDA Label Image

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 06)

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 06)
Erlotinib Tablets 25 mg oral tablets label by Zydus Pharmaceuticals USA Inc. The label states 30 tablets per package, Rx only. It includes storage instructions, child-resistant packaging notice, and manufacturer information for Zydus Lifesciences Ltd. with distribution by Zydus Pharmaceuticals (USA) Inc.*
FDA Label Image

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 07)

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 07)
Erlotinib Tablets 100 mg oral tablets packaging label from Zydus Pharmaceuticals USA Inc. The label shows 30 tablets per bottle, Rx only, and includes storage instructions and manufacturer information from Zydus Lifesciences Ltd. The label also states the package is child-resistant and provides the NDC 68382-914-06.*
FDA Label Image

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 08)

Image (E34fafdf 2fda 4031 9202 6d7e85925dc1 08)
Erlotinib Tablets 150 mg oral tablet packaging label from Zydus Pharmaceuticals USA Inc. The label indicates the package contains 30 film-coated tablets, Rx only. Storage instructions and manufacturer details are also provided, including that each tablet contains the equivalent of 150 mg erlotinib. The label features the NDC 68382-915-06 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.